PERRIGO UK FINCO
GenericsPERRIGO UK FINCO is a generic drug manufacturer focused on Neurology.
PERRIGO UK FINCO's Key Drugs
PERRIGO UK FINCO's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
PERRIGO UK FINCO's Recent FDA Approvals
New NDA/BLA approvals for PERRIGO UK FINCO over the last two years — novel drugs only, excluding generics and label supplements.
PERRIGO UK FINCO's Therapeutic Areas
PERRIGO UK FINCO's approved drugs and pipeline span 1 therapeutic area, led by Neurology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
PERRIGO UK FINCO's Top Competitors
PERRIGO UK FINCO's closest competitors by therapeutic-area and drug-target overlap include Pfizer, AbbVie, and Eli Lilly. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
PERRIGO UK FINCO Pipeline Snapshot
Active clinical trials for PERRIGO UK FINCO across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Neurology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2020-09-21
- Latest
- 2020-09-21
- Applications
- 3